Khadije Shahrokhabadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Khadije Shahrokhabadi has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Javad Baharara
Department of Biology & Research Center for Animal Development Applied Biology, Mashahad Branch, Islamic Azad University, Mashahad, Iran
2 shared publications Arezoo Akmali
MSc, Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran
1 shared publication- Armin Attaranzadeh
Mashhad University of Medical Sciences, Mashhad, Iran.
1 shared publication - Fazeleh Moshfegh
Department of Biology, Faculty of Basic Science, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
1 shared publication - Khadijeh Shahrokhabadi
Department of Biology, Mashhad branch, Islamic Azad university, Mashhad, Iran
1 shared publication - M Lotfi1 shared publication
Latest Publications
- 24 December 2025
- Published by Springer Nature in Reproductive Sciences
- Vol. 33 (1) , 214-221
Evaluation of the DNA Repair Mechanism Following In Vitro Maturation of Mouse Oocytes
- 24 December 2025
- Published by Springer Nature in Reproductive Sciences
- Vol. 33 (1) , 214-221
Evaluation of the DNA Repair Mechanism Following In Vitro Maturation of Mouse Oocytes
- Open Access
- 22 December 2025
- Published by InkVista Publishing House in Cell and Tissue Journal
- Vol. 16 (4) , 352-368
The Synergistic Effect of Stem Cell-Derived Exosomes and Glucosamine on the Expression of Sox9, Acan, Col2a1, and Col10a1 Genes in Bone Marrow Mesenchymal Stem Cells of NMRI Mice in a Chondrogenic Medium
هدف: غضروفها فاقد رگ خونی و دارای توانایی ترمیم محدود میباشند. بازسازی آسیب غضروفی بهعنوان یک چالش باقی مانده است. اگزوزومها وزیکولهای خارج سلولی میباشند که از انواع مختلفی از سلولها آزاد میشوند. از طرف دیگر مشاهده شده که گلوکزآمین بهعنوان دارو نقش مهمی در بازسازی غضروف ایفا میکند. هدف از این پژوهش بررسی تاثیر توام اگزوزومهای مشتق از سلولهای بنیادی مغز استخوان موش و گلوکز آمین بر بیان ژنهای اختصاصی غضروف میباشد. مواد و روشها: سلولهای بنیادی مزانشیمی مغز استخوان موش کوچک آزمایشگاهی کشت داده شدند و اگزوزومها از محیط رویی سلولها بهروش التراسانتریفیوژ استخراج شد. اثرات اگزوزوم و گلوکزآمین بر بیان ژنهای Sox9، Acan، Col2a1 و Col10a1 در سلولهای بنیادی مزانشیمی در حضور محیط کندروژنیک بررسی شد. نتایج: نتایج شناسایی، حضور اگزوزومها با اندازهی تقریبی 100 نانومتر را تایید کردند و همچنین نتایج Real time PCR نشان داد که بیان ژنهای Sox9، Acan و Col2a1 در سلولهای بنیادی تحت تیمار توام با اگزوزوم و گلوکزآمین نسبت به سایر گروهها پس از 14 روز افزایش معنی دار و همچنین بیان ژن Col10a1 کاهش معنادار داشته است. نتیجهگیری: ترکیب اگزوزومهای مشتق از...
- 22 December 2025
- Published by InkVista Publishing House in Cell and Tissue Journal
- Vol. 16 (4) , 352-368
Open AccessThe Synergistic Effect of Stem Cell-Derived Exosomes and Glucosamine on the Expression of Sox9, Acan, Col2a1, and Col10a1 Genes in Bone Marrow Mesenchymal Stem Cells of NMRI Mice in a Chondrogenic Medium
هدف: غضروفها فاقد رگ خونی و دارای توانایی ترمیم محدود میباشند. بازسازی آسیب غضروفی بهعنوان یک چالش باقی مانده است. اگزوزومها وزیکولهای خارج سلولی میباشند که از انواع مختلفی از سلولها آزاد میشوند. از طرف دیگر مشاهده شده که گلوکزآمین بهعنوان دارو نقش مهمی در بازسازی غضروف ایفا میکند. هدف از این پژوهش بررسی تاثیر توام اگزوزومهای مشتق از سلولهای بنیادی مغز استخوان موش و گلوکز آمین بر بیان ژنهای اختصاصی غضروف میباشد. مواد و روشها: سلولهای بنیادی مزانشیمی مغز استخوان موش کوچک آزمایشگاهی کشت داده شدند و اگزوزومها از محیط رویی سلولها بهروش التراسانتریفیوژ استخراج شد. اثرات اگزوزوم و گلوکزآمین بر بیان ژنهای Sox9، Acan، Col2a1 و Col10a1 در سلولهای بنیادی مزانشیمی در حضور محیط کندروژنیک بررسی شد. نتایج: نتایج شناسایی، حضور اگزوزومها با اندازهی تقریبی 100 نانومتر را تایید کردند و همچنین نتایج Real time PCR نشان داد که بیان ژنهای Sox9، Acan و Col2a1 در سلولهای بنیادی تحت تیمار توام با اگزوزوم و گلوکزآمین نسبت به سایر گروهها پس از 14 روز افزایش معنی دار و همچنین بیان ژن Col10a1 کاهش معنادار داشته است. نتیجهگیری: ترکیب اگزوزومهای مشتق از...
- Open Access
- 29 November 2022
- Published by DoNotEdit
- Vol. 14 (4) , 23-29
Investigating the relationship between C-159T polymorphism in CD14 gene promoter and disease severity in 2019 corona virus patients
Introduction: Considering the effectiveness of polymorphisms in the occurrence of respiratory diseases, it seems that these genetic variations in viral and microbial receptors can be effective in the occurrence and progression of the disease. The present study aimed to assess the relationship between the C-159T polymorphism in the CD14 gene promoter and the severity of the disease in Covid-19 patients during 2020-2021. Method: The subjects were randomly selected from subjects referred for polymerase chain reaction (PCR) and studied in five groups: healthy, outpatient, non-critically ill hospitalized, critically ill hospitalized, and deceased patients. The peripheral blood (3ml) was obtained from all patients and DNA was extracted. Thereafter, C-159T polymorphism in the CD14 gene promoter was determined by PCR-restriction fragment length polymorphism (RFLP) method. The genotype frequency was determined in terms of heterozygosity, homozygosity, and mutant regarding polymorphism. The data were analyzed in SPSS software (version 21) (P<0.05). Results: The results pointed out that the most common C-159T polymorphism was the CT polymorphism, which was observed in 107 (51.0%) subjects and was significantly higher than other polymorphisms in all PCR- and PCR+ participants. This difference was not significant for deceased people. Conclusion: According to the results pointing out that the C-159T polymorphism is effective in causing the disease, as well as the significant relationship between the TT and CT genotypes with the coronavirus, the probability of developing the disease is higher in T allele carriers. Therefore, it is suggested that CT polymorphism in CD14 gene promoter is considered an important prognosis in coronavirus disease.
- 29 November 2022
- Published by DoNotEdit
- Vol. 14 (4) , 23-29
Open AccessInvestigating the relationship between C-159T polymorphism in CD14 gene promoter and disease severity in 2019 corona virus patients
Introduction: Considering the effectiveness of polymorphisms in the occurrence of respiratory diseases, it seems that these genetic variations in viral and microbial receptors can be effective in the occurrence and progression of the disease. The present study aimed to assess the relationship between the C-159T polymorphism in the CD14 gene promoter and the severity of the disease in Covid-19 patients during 2020-2021. Method: The subjects were randomly selected from subjects referred for polymerase chain reaction (PCR) and studied in five groups: healthy, outpatient, non-critically ill hospitalized, critically ill hospitalized, and deceased patients. The peripheral blood (3ml) was obtained from all patients and DNA was extracted. Thereafter, C-159T polymorphism in the CD14 gene promoter was determined by PCR-restriction fragment length polymorphism (RFLP) method. The genotype frequency was determined in terms of heterozygosity, homozygosity, and mutant regarding polymorphism. The data were analyzed in SPSS software (version 21) (P<0.05). Results: The results pointed out that the most common C-159T polymorphism was the CT polymorphism, which was observed in 107 (51.0%) subjects and was significantly higher than other polymorphisms in all PCR- and PCR+ participants. This difference was not significant for deceased people. Conclusion: According to the results pointing out that the C-159T polymorphism is effective in causing the disease, as well as the significant relationship between the TT and CT genotypes with the coronavirus, the probability of developing the disease is higher in T allele carriers. Therefore, it is suggested that CT polymorphism in CD14 gene promoter is considered an important prognosis in coronavirus disease.